Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: The fact that we are not seeing more licenses

RE: The fact that we are not seeing more licenses

posted on Jul 14, 2006 02:14PM
may be because the dollars for licenses for this quarter is enough to show positive growth. Announcing any more deals may send the PPS higher which is not what PTSC wants at this time for share buy back.

Perhaps PTSC was not buying around a $1.00 and the ratcheting down of the PPS is occurring to get at the buy level.

All IMHO

All the best,

Steve

Share
New Message
Please login to post a reply